NYSE
$6.34▼ 1.63%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.37BShares out 3.700M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
7- 10.2After-hours26.10.03 05:464Ownership#●●●
Bausch Health Companies Inc.
Insider John Paulson has filed a Form 4 for Bausch Health Companies Inc., reporting changes in beneficial ownership of securities as of September 30, 2026. This filing officially documents the insider's equity transaction.…more
$6.34-1.63%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.2After-hours26.10.03 05:274Ownership
Bausch Health Companies Inc.
Executive Sandra Leung of Bausch Health Companies Inc. reported a change in beneficial ownership of securities as of September 30, 2026. This filing serves as a Form 4 statement submitted to the SEC regarding the executive's equity holdings.…more
$6.34-1.63%vs prev closeView filingShare - 10.2After-hours26.10.03 05:184Ownership
Bausch Health Companies Inc.
Insider Amy B. Wechsler of Bausch Health Companies Inc. reported a change in beneficial ownership of securities effective September 30, 2026. This filing serves as an official notification to the SEC regarding the insider's equity position change.…more
$6.34-1.63%vs prev closeView filingShare
6 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 6d agoPre-market26.10.19 21:08Bullish#●●●#●●●
Bausch Health Expands Public Reimbursement for PrOKEDI in Canada
Bausch Health's schizophrenia treatment, PrOKEDI, has been added to public drug plans across seven Canadian provinces and multiple federal programs. This expansion improves patient access and is expected to support the product's commercial growth.…more
$6.34-1.63%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.12Regular26.10.13 03:13
●●●●●●●● ●●●●● ●●●●●●
Bausch + Lomb shares fell nearly 10% after the company announced the departure of CEO Brent Saunders and the appointment of Thomas J. Appio as interim CEO. Despite the company signaling an increase in full-year earnings guidance, the sudden leadership transition triggered investor uncertainty.…more
$6.34-1.63%vs prev closeShareBenzinga - 10.12Pre-market26.10.12 21:06
●●●●●●●● ●●●●● ●●●●●●
Bausch Health's Salix division announced that its cirrhosis care pathway pilot program increased hepatic encephalopathy treatment rates from 60.2% to 64.9%. While this indicates improved clinical efficiency, the lack of direct financial impact data results in a neutral outlook.…more
$6.34-1.63%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report